EMERGING TESTS

Progress Seen With EGFR Testing, But Adoption Still Lagging

Incomplete implementation of EGFR testing guidelines remains a problem in the realm of non-small cell lung cancer (NSCLC), according to a study published in the Journal of Global Oncology. The authors … [Read more...]

GENETIC TESTING

ASCO Endorses CAP’s Practice Guidelines for HPV Testing in Head, Neck Cancers

The American Society of Clinical Oncology endorsed the American Pathologists' practice guidelines for human papillomavirus (HPV) testing in head and neck cancers. The guidelines recommend that HPV … [Read more...]

TESTING STRATEGY

Preventive Genomic Screening In Young Adults Highly Cost Effective

A new model shows that universal preventive genomic screening for multiple conditions in early adulthood could be highly cost-effective in a single-payer health care system, according to a study … [Read more...]

INDUSTRY TRENDS

Laboratory Initiation of Cascade Genetic Testing Spurs Uptake

A laboratory-initiated, online effort to reach cancer patients' relatives coupled with discounted genetic tests can increase rates of cascade testing, according to a study published in the January … [Read more...]

PRECISION MEDICINE

Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies

Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last 10 years. While whole-exome sequencing (WES) has shown utility … [Read more...]

PRECISION MEDICINE

Donor-Derived, Cell-Free DNA May Predict Lung Transplant Rejection

Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and predict progression to chronic rejection, according to a … [Read more...]

TOP OF THE NEWS

Genetic Risk of Prostate Cancer Underestimated; Testing Guidelines Miss Men With Elevated Prostate Cancer Risk

Neither guideline eligibility nor Gleason scores are reliable for predicting prostate cancer risk due to pathogenic germline variants, according to a study published Feb. 7 in JAMA Oncology. The … [Read more...]

TESTING STRATEGY

New Studies Question Utility of Gene Expression Testing for Cancers With Unknown Primary Site, Low-Risk Breast Cancer

Gene expression profiling has been making inroads into clinical cancer care, with application in cancer classification, most notably with breast cancer. Two recent studies are calling into question … [Read more...]

EMERGING TESTS

Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]

INDUSTRY TRENDS

Diagnostics Sector Saw Increased Investment, Exits in 2018

Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]


(-00000g2)